Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Betta Pharmaceuticals Co., Ltd.
  6. Summary
    300558   CNE100002DD9

BETTA PHARMACEUTICALS CO., LTD.

(300558)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
119.65 112.34 112.71 112.68 106.95 Last
3267362 5186644 2529000 2490650 5810212 Volume
+1.76% -6.11% +0.33% -0.03% -5.09% Change
Financials
Sales 2021 2 451 M 383 M 383 M
Net income 2021 465 M 72,7 M 72,7 M
Net cash position 2021 1 329 M 208 M 208 M
P/E ratio 2021 97,5x
Yield 2021 0,28%
Sales 2022 3 460 M 541 M 541 M
Net income 2022 649 M 101 M 101 M
Net cash position 2022 1 819 M 284 M 284 M
P/E ratio 2022 68,3x
Yield 2022 0,54%
Capitalization 44 188 M 6 906 M 6 908 M
EV / Sales 2021 17,5x
EV / Sales 2022 12,2x
Nbr of Employees 1 328
Free-Float 100%
More Financials
Company
Betta Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the research and development, manufacturing, sales and marketing of drugs to treat malignant tumors, diabetes, cardiovascular and cerebrovascular diseases. The Company’s core product is icotinib, which is a kind of antineoplastic agent. Its products also include burn pain relieving plaster, oryzanol vitamin B1 and vitamin B6 tablets.... 
Read more
Sector
Pharmaceuticals
Calendar
08/26Earnings Release
More about the company
Ratings of Betta Pharmaceuticals Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about BETTA PHARMACEUTICALS CO., LTD.
06/08MARKET CHATTER : Chaoju Eye Care Set for Hong Kong Listing Hearing This Week
MT
06/08MARKET CHATTER : China Tourism Group Eyes Secondary Listing in Hong Kong to Rais..
MT
06/06MARKET CHATTER : Chinese Bubble Tea Chain Operator Nayuki Passes Hong Kong Listi..
MT
06/01MARKET CHATTER : Chinese Bubble Tea Chain Operator Nayuki Set for Hong Kong List..
MT
05/25MARKET CHATTER : Betta Pharmaceuticals Set for Hong Kong Listing Hearing This We..
MT
More news
News in other languages on BETTA PHARMACEUTICALS CO., LTD.

- No features available -

More news
Chart BETTA PHARMACEUTICALS CO., LTD.
Duration : Period :
Betta Pharmaceuticals Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BETTA PHARMACEUTICALS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 139,16 CNY
Last Close Price 106,95 CNY
Spread / Highest target 33,0%
Spread / Average Target 30,1%
Spread / Lowest Target 27,3%
EPS Revisions
Managers and Directors
NameTitle
Lie Ming Ding Chairman, Co-Chief Executive Officer & GM
Jia Tong Co-Chief Executive Officer & Secretary
Jian Xun Fan Chief Financial Officer & Vice President
Yang Nan Zhang Chairman-Supervisory Board
Jia Bing Wang Director, Senior Vice President & Chief Scientist
Sector and Competitors
1st jan.Capitalization (M$)
BETTA PHARMACEUTICALS CO., LTD.-0.39%6 906
MERCK KGAA10.55%81 596
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD51.17%38 130
KYOWA KIRIN CO., LTD.31.66%18 130
SK BIOPHARMACEUTICALS CO., LTD.-28.11%8 516
YUHAN CORPORATION-13.18%3 813